Trial Information

Merck MK0653C in High Heart/Blood Vessel Risk Individuals With High Cholesterol

We are conducting a research study to compare the effectiveness and safety of taking ezetimibe (Zetia) and atorvastatin (Lipitor) together compared to taking atorvastatin (Lipitor) or rosuvastatin (Crestor) alone. For more information, visit the study's pages at clinicaltrials.gov.

Duration: 8 outpatient visits

Compensation: Investigational cholesterol lowering medication and study-related care at no cost, as well as compensation for time. Reimbursement for childcare and transportation may be provided

Patient Inclusion Criteria:

18 to 80 years
diagnosed with high cholesterol
taking a stable dose of cholesterol lowering medication for at least 6 months or
not taking medication for high cholesterol for at least 6 months

Patient Exclusion Criteria:

Of Asian decent
Pregnant or breast-feeding
poorly controlled Type I or Type II Diabetes mellitus
Congestive heart failure
HIV positive
History of Cancer less than 5 years
Treatment with other investigational drug less than 30 days

Amie Piepergerdes, Coordinator
Dybedal Clinical Research Center
1750 Independence Ave
Kansas City, MO 64106
Phone: 816-283-2335
Fax: 816-283-2376
Email: CRC@KCUMB.EDU

View Map

Research Center Information: Dybedal Clinical Research Center

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:
Message:

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.